Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (61)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Weber, G.
Right arrow Articles by Larsson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, G.
Right arrow Articles by Larsson, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

OTHER

The phospholipase C ß3 gene located in the MEN1 region shows loss of expression in endocrine tumours

Günther Weber1,*, Eitan Friedman1, Sean Grimmond2, Nicholas K. Hayward2, Catherine Phelan1, Britt Skogseid3, Anders Gobl3, Jan Zedenius1,4, Kerstin Sandelin4, Bin Tean Teh1,2, Emma Carson1, Irene White1, Kjell Öberg3, Joseph Shepherd5, Magnus Nordenskjöld1 and Catharina Larsson1

1Department of Clinical Genetics, Karolinska Hospital S-171 76 Stockholm, Sweden 2Queensland Cancer Fund Research Unit, Joint Experimental Oncology Program, Queensland, Institute for Medical Research, Herston Queensland 4029, Australia 3Department of Internal Medicine, University Hospital S-751 85 Uppsala 4Department of Surgery, Karolinska Hospital S-104 01 Stockholm, Sweden 5Department of Surgery, University of Tasmania, Royal Hobart Hospital Hobart, Tasmania 700, Australia

*To whom correspondence should be addressed

Received May 16, 1994; Revised August 4, 1994; Accepted August 4, 1994

Oncogenesis of tumours related to multiple endocrine neoplasia type 1 (MEN1) is associated with somatic deletions involving the MEN1 locus, suggesting inactivation of a tumour suppressor gene in this region. Identification of meiotic cross-overs in MEN1 families has placed the MEN1 locus centromeric of D11S807. An extended deletion mapping was performed in 27 primary parathyroid tumours, and identified D11S427 as the closest centromeric flanking marker. Through physical mapping using newly isolated cDNA clones, we estimated the distance between the flanking markers D11S807 and D11S427 to be less than 900 kb. One of these cDNA clones showed expression of a 4.4 kb message in multiple tissues, including those affected in MEN1, while in five endocrine tumours no transcript was detected. Sequence characterization showed that this gene encodes for the phospholipase C ß3, a key enzyme in signal transduction.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Genome ResHome page
C. M. Smith, N. S. Ma, N. J. Nowak, T. B. Shows, and D. S. Gerhard
A 3-Mb Contig from D11S987 to MLK3, a Gene-Rich Region in 11q13
Genome Res., August 1, 1997; 7(8): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
S. C. Guru, S. K. Agarwal, P. Manickam, S.-E. Olufemi, J. S. Crabtree, J. M. Weisemann, M. B. Kester, Y. S. Kim, Y. Wang, M. R. Emmert-Buck, et al.
A Transcript Map for the 2.8-Mb Region Containing the Multiple Endocrine Neoplasia Type 1 Locus
Genome Res., July 1, 1997; 7(7): 725 - 735.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Q. Dong, L. V. Debelenko, S. C. Chandrasekharappa, M. R. Emmert-Buck, Z. Zhuang, S. C. Guru, P. Manickam, M. Skarulis, I. A. Lubensky, L. A. Liotta, et al.
Loss of Heterozygosity at 11q13: Analysis of Pituitary Tumors, Lung Carcinoids, Lipomas, and Other Uncommon Tumors in Subjects with Familial Multiple Endocrine Neoplasia Type 1
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1416 - 1420.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. L. Stock, M. R. Warth, B. T. Teh, J. A. Coderre, J. H. Overdorf, G. Baumann, R. L. Hintz, M. L. Hartman, B. R. Seizinger, C. Larsson, et al.
A Kindred with a Variant of Multiple Endocrine Neoplasia Type 1 Demonstrating Frequent Expression of Pituitary Tumors but Not Linked to the Multiple Endocrine Neoplasia Type 1 Locus at Chromosome Region 11q13
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 486 - 492.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. B. Lieberman, K. M. Hopkins, M. Nass, D. Demetrick, and S. Davey
A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene
PNAS, November 26, 1996; 93(24): 13890 - 13895.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
S Grimmond, J Lagercrantz, C Drinkwater, G Silins, S Townson, P Pollock, D Gotley, E Carson, S Rakar, M Nordenskjold, et al.
Cloning and characterization of a novel human gene related to vascular endothelial growth factor.
Genome Res., February 1, 1996; 6(2): 124 - 131.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C. Yue, C.-Y. Ku, M. Liu, M. I. Simon, and B. M. Sanborn
Molecular Mechanism of the Inhibition of Phospholipase C beta 3 by Protein Kinase C
J. Biol. Chem., September 22, 2000; 275(39): 30220 - 30225.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.